A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR®) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.

Part of paid clinical trials in Buffalo, New York.

Sponsor
Renovo Concepts, Inc.
Study ID
NCT06201429
Status
Recruiting

Conditions

  • Clinical Need for Cranioplasty
  • Clinical Need for Craniotomy or Craniectomy

Eligibility Criteria

Sex
ALL
Age
22 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Mechanical Tissue Resuscitation™ (MTR®) — DEVICE
    Mechanical Tissue Resuscitation™ (MTR®) to drain excess fluid volume from the site of surgery in patients who have undergone a surgical procedure (craniotomy/craniectomy), or a procedure in which a portion of the skull has been repaired or replaced (cranioplasty), and who, as an integral part of their care would require placement of a Jackson Pratt drain (or equivalent).

Study Details

A multi-center, early feasibility study of using the Mechanical Tissue Resuscitation™ (MTR®) therapy system for removal of excess fluid in subjects who have had a portion of their skull removed to expose the dura/brain and require drainage for fluid removal.

Key Dates

Start date
Nov 1, 2024
Status verified
Apr 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
11 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Mechanical Tissue Resuscitation™ (MTR®)

Primary Outcome Measure

Safety and effectiveness of MTR® [ Time Frame: 30 days ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University at Buffalo NeurosurgeryBuffaloNew York14203-
Atrium Health Wake Forest BaptistWinston-SalemNorth Carolina27157-
West Virginia UniversityMorgantownWest Virginia26506-

Find similar trials in Buffalo, NY